THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER

被引：0

作者：

Van Rhijn, B. W. G. ^{[1
]}

Bapat, B. ^{[2
]}

Van Der Kwast, T. H. ^{[3
]}

Liu, L. ^{[2
]}

Fleshner, N. E. ^{[1
]}

Van Der Aa, M. N. M. ^{[4
]}

Vajpeyi, R. ^{[1
]}

Bangma, C. H. ^{[4
]}

Zwarthoff, E. C. ^{[5
]}

Jewett, M. A. S. ^{[1
]}

Zlotta, A. R. ^{[1
]}

机构：

[1] Univ Toronto, Univ Hlth Network, Dept Surg Oncol Urol, Toronto, ON, Canada

[2] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada

[3] Univ Toronto, Univ Hlth Network, Dept Surg Pathol, Toronto, ON, Canada

[4] Erasmus MC, Dept Urol, Rotterdam, Netherlands

[5] Erasmus MC, Dept Pathol, Rotterdam, Netherlands

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期

关键词：

D O I：

10.1016/S1569-9056(09)60313-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：197 / 197

页数：1

共 50 条

[1] The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer
van Rhijn, Bas W. G.
van der Kwast, Theo H.
Liu, Liyang
Fleshner, Neil E.
Bostrom, Peter J.
Vis, Andre N.
Alkhateeb, Sultan S.
Bangma, Chris H.
Jewett, Michael A. S.
Zwarthoff, Ellen C.
Zlotta, Alexandre R.
Bapat, Bharati
JOURNAL OF UROLOGY, 2012, 187 (01): : 310 - 314
[2] THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER
Van Rhijn, Bas W.
Bapat, Bharati
Van der Kwast, Theo H.
Liu, Liyang
Fleshner, Neil E.
Vajpeyi, Rati
Van der Aa, Madelon N.
Bangma, Chris H.
Zwarthoff, Ellen C.
Jewett, Michael A. S.
Zlotta, Alexandre R.
JOURNAL OF UROLOGY, 2009, 181 (04): : 308 - 309
[3] Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status
Kang, Ho Won
Kim, Ye-Hwan
Jeong, Pildu
Park, Cheol
Kim, Won Tae
Ryu, Dong Hee
Cha, Eun-Jong
Ha, Yun-Sok
Kim, Tae-Hwan
Kwon, Tae Gyun
Moon, Sung-Kwon
Choi, Yung Hyun
Yun, Seok-Joong
Kim, Wun-Jae
ONCOLOGY LETTERS, 2017, 14 (03) : 3817 - 3824
[4] FGFR3 PROTEIN OVER-EXPRESSION IN THE ABSENCE OF A FGFR3 MUTATION IS NOT ASSOCIATED WITH FAVORABLE DISEASE CHARACTERISTICS IN BLADDER CANCER
Van Rhijn, B. W. G.
Bapat, B.
Liyang, L.
Bostrom, P. J.
Fleshner, N. E.
Jewett, M. A. S.
Zlotta, A. R.
Van Der Kwast, Th. H.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 197 - 197
[5] THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER
van Rhijn, Bas W.
Bostrom, Peter J.
Shariat, Shahrokh F.
Finelli, Antonio
Sagalowsky, Arthur I.
Fleshner, Neil E.
Bapat, Bharati
Kortekangas, Hannes
Ashfaq, Raheela
Mirtti, Tuomas
Jewett, Michael A.
Lotan, Yair
van der Kwast, Theo H.
Zlotta, Alexandre R.
JOURNAL OF UROLOGY, 2011, 185 (04): : E561 - E561
[6] THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER
Van Rhijn, B. W. G.
Bostrom, P. J.
Shariat, S. F.
Finelli, A.
Sagalowsky, A., I
Fleshner, N. E.
Bapat, B.
Kortekangas, H.
Ashfaq, R.
Mirtti, T.
Jewett, M. A. S.
Lotan, Y.
Van Der Kwast, Th. H.
Zlotta, A. R.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 243 - 243
[7] FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer
Mhawrech-Fauceglia, P
Cheney, RT
Fischer, G
Beek, A
Herrmann, FR
EJSO, 2006, 32 (02): : 231 - 237
[8] Significance of the FGFR3 mutation in Chinese patients with bladder cancer
Hao, Lanxiang
Fang, Jiang
Xu, Ran
Liu, Shuo
Luo, Guangcheng
Wang, Xinjun
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (05) : 761 - +
[9] FGFR3 PROTEIN OVER-EXPRESSION IN THE ABSENCE OF A FGFR3 MUTATION IS NOT ASSOCIATED WITH FAVOURABLE DISEASE CHARACTERISTICS IN BLADDER CANCER
van Rhijn, Bas
Bapat, Bharati
Liu, Liyang
Bostrom, Peter
Fleshner, Neil
Jewett, Michael
Zlotta, Alexandre
van der Kwast, Theo
JOURNAL OF UROLOGY, 2010, 183 (04): : E444 - E444
[10] FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer
Xu, Pei-Hang
Chen, Siyuan
Wang, Yanhao
Jin, Shengming
Wang, Jun
Ye, Dingwei
Zhu, Xiaodong
Shen, Yijun
COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 162

← 1 2 3 4 5 →